Stay updated with breaking news from Applied Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Venlo, the Netherlands, April 24, 2023 -- QIAGEN announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory... | April 24, 2023
Two-day hybrid event to address current challenges in cancer treatment and diagnostics Uniting researchers, oncologists and data specialists... | April 18, 2023
QIAGEN N.V. to release results for Q1 2023 and hold webcast Venlo, The Netherlands, April 18, 2023 - QIAGEN N.V. announced its plans to release results for the... | April 18, 2023
Venlo, the Netherlands, April 14, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December